Design and validation of a specific scavenger receptor class AI binding peptide for targeting the inflammatory atherosclerotic plaque

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 32, Issue 4, 2012, Pages 971-978

  Segers, Filip M E ^a,c   Yu, Haixiang ^b   Molenaar, Tom J M ^c   Prince, Perry ^c   Tanaka, Toshiki ^d   Van Berkel, Theo J C ^c   Biessen, Erik A L ^c,e  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c LEIDEN UNIVERSITY   (Netherlands)

^d NAGOYA INSTITUTE OF TECHNOLOGY   (Japan)

^e MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

atherosclerosis; foam cells; lipoproteins; macrophages; receptors

Indexed keywords

APOLIPOPROTEIN E; BINDING PROTEIN; SCAVENGER RECEPTOR AI BINDING PHAGE; STREPTAVIDIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA ATHEROSCLEROSIS; ARTICLE; ATHEROSCLEROTIC PLAQUE; BINDING AFFINITY; BINDING COMPETITION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IC 50; INTERNALIZATION; LIGAND BINDING; MACROPHAGE; MOLECULAR DOCKING; MOLECULAR LIBRARY; MOUSE; NONHUMAN; PEPTIDE SYNTHESIS; PHAGE DISPLAY; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; AUTORADIOGRAPHY; BINDING, COMPETITIVE; CERCOPITHECUS AETHIOPS; COS CELLS; DISEASE MODELS, ANIMAL; DRUG CARRIERS; FEMALE; HUMANS; INFLAMMATION; LIGANDS; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PEPTIDE LIBRARY; PEPTIDES; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN INTERACTION MAPPING; SCAVENGER RECEPTORS, CLASS A; STREPTAVIDIN;

EID: 84863337929     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.111.235358     Document Type: Article

References (39)

1. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med. 1999; 340:115-126.
2. Kodama T, Freeman M, Rohrer L, Zabrecky J, Matsudaira P, Krieger M. Type I macrophage scavenger receptor contains γ-helical and collagen-like coiled coils. Nature. 1990;343:531-535.
3. Penman M, Lux A, Freedman NJ, Rohrer L, Ekkel Y, McKinstry H, Resnick D, Krieger M. The type I and type II bovine scavenger receptors expressed in Chinese hamster ovary cells are trimeric proteins with collagenous triple helical domains comprising noncovalently associated monomers and Cys83-disulfide-linked dimers. J Biol Chem. 1991;266: 23985-23993. (Pubitemid 21908894)
4. Suzuki H, Kurihara Y, Takeya M, Kamada N, Kataoka M, Jishage K, Ueda O, Sakaguchi H, Higashi T, Suzuki T, Takashima Y, Kawabe Y, Cynshi O, Wada Y, Honda M, Kurihara H, Aburatani H, Doi T, Matsumoto A, Azuma S, Noda T, Toyoda Y, Itakura H, Yazaki Y, Horiushi S, Takahashi K, Kruijt JK, van Berkel TJ, Steinbrecher UP, Ishibashi S, Maeda N, Gordon S, Kodama T. A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection. Nature. 1997;386:292-296. (Pubitemid 27142516)
5. Gough PJ, Greaves DR, Gordon S. A naturally occurring isoform of the human macrophage scavenger receptor (SR-A) gene generated by alternative splicing blocks modified LDL uptake. J Lipid Res. 1998;39: 531-543. (Pubitemid 28158396)
6. Rohrer L, Freeman M, Kodama T, Penman M, Krieger M. Coiled-coil fibrous domains mediate ligand binding by macrophage scavenger receptor type II. Nature. 1990;343:570-572.
7. Tanaka T, Nishikawa A, Tanaka Y, Nakamura H, Kodama T, Imanishi T, Doi T. Synthetic collagen-like domain derived from the macrophage scavenger receptor binds acetylated low-density lipoprotein in vitro. Protein Eng. 1996;9:307-313. (Pubitemid 26148311)
8. Doi T, Higashino K, Kurihara Y, Wada Y, Miyazaki T, Nakamura H, Uesugi S, Imanishi T, Kawabe Y, Itakura H, Yazaki Y, Matsumoto A, Kodama T. Charged collagen structure mediates the recognition of negatively charged macromolecules by macrophage scavenger receptors. J Biol Chem. 1993;268:2126-2133. (Pubitemid 23033623)
9. Nagelkerke JF, Barto KP, van Berkel TJ. In vivo and in vitro uptake and degradation of acetylated low density lipoprotein by rat liver endothelial, Kupffer, and parenchymal cells. J Biol Chem. 1983;258:12221-12227. (Pubitemid 14230009)
10. Dunne DW, Resnick D, Greenberg J, Krieger M, Joiner KA. The type I macrophage scavenger receptor binds to gram-positive bacteria and recognizes lipoteichoic acid. Proc Natl Acad Sci USA. 1994;91:1863-1867. (Pubitemid 24080306)
11. Van Berkel TJ, Van Velzen A, Kruijt JK, Suzuki H, Kodama T. Uptake and catabolism of modified LDL in scavenger-receptor class A type I/II knock-out mice. Biochem J. 1998;331:29-35. (Pubitemid 28163953)
12. Pitas RE. Expression of the acetyl low density lipoprotein receptor by rabbit fibroblasts and smooth muscle cells: up-regulation by phorbol esters. J Biol Chem. 1990;265:12722-12727.
13. Gough PJ, Greaves DR, Suzuki H, Hakkinen T, Hiltunen MO, Turunen M, Herttuala SY, Kodama T, Gordon S. Analysis of macrophage scavenger receptor (SR-A) expression in human aortic atherosclerotic lesions. Arterioscler Thromb Vasc Biol. 1999;19:461-471. (Pubitemid 29135143)
14. de Winther MP, van Dijk KW, Havekes LM, Hofker MH. Macrophage scavenger receptor class A: a multifunctional receptor in atherosclerosis. Arterioscler Thromb Vasc Biol. 2000;20:290-297. (Pubitemid 30086083)
15. Babaev VR, Gleaves LA, Carter KJ, Suzuki H, Kodama T, Fazio S, Linton MF. Reduced atherosclerotic lesions in mice deficient for total or macrophage-specific expression of scavenger receptor-A. Arterioscler Thromb Vasc Biol. 2000;20:2593-2599.
16. Li AC, Glass CK. The macrophage foam cell as a target for therapeutic intervention. Nat Med. 2002;8:1235-1242. (Pubitemid 35373554)
17. Amirbekian V, Lipinski MJ, Briley-Saebo KC, Amirbekian S, Aguinaldo JG, Weinreb DB, Vucic E, Frias JC, Hyafil F, Mani V, Fisher EA, Fayad ZA. Detecting and assessing macrophages in vivo to evaluate atherosclerosis noninvasively using molecular MRI. Proc Natl Acad Sci USA. 2007;104:961-966. (Pubitemid 46154719)
18. Briley-Saebo KC, Shaw PX, Mulder WJ, Choi SH, Vucic E, Aguinaldo JG, Witztum JL, Fuster V, Tsimikas S, Fayad ZA. Targeted molecular probes for imaging atherosclerotic lesions with magnetic resonance using antibodies that recognize oxidation-specific epitopes. Circulation. 2008; 117:3206-3215.
19. Lysko PG, Weinstock J, Webb CL, Brawner ME, Elshourbagy NA. Identification of a small-molecule, nonpeptide macrophage scavenger receptor antagonist. J Pharmacol Exp Ther. 1999;289:1277-1285. (Pubitemid 29246655)
20. 't Hoen PA, Van der Lans CA, Van Eck M, Bijsterbosch MK, Van Berkel TJ, Twisk J. Aorta of apoE-deficient mice responds to atherogenic stimuli by a prelesional increase and subsequent decrease in the expression of antioxidant enzymes. Circ Res. 2003;93:262-269. (Pubitemid 36993238)
21. van Zonneveld AJ, van den Berg BM, van Meijer M, Pannekoek H. Identification of functional interaction sites on proteins using bacteriophagedisplayed random epitope libraries. Gene. 1995;167:49-52.
22. Bartoli F, Nuzzo M, Urbanelli L, Bellintani F, Prezzi C, Cortese R, Monaci P. DNA-based selection and screening of peptide ligands. Nat Biotechnol. 1998;16:1068-1073. (Pubitemid 28515902)
23. Molenaar TJ, Michon I, de Haas SA, van Berkel TJ, Kuiper J, Biessen EA. Uptake and processing of modified bacteriophage M13 in mice: implications for phage display. Virology. 2002;293:182-191.
24. Suzuki K, Yamada T, Tanaka T. Role of the buried glutamate in the-helical coiled coil domain of the macrophage scavenger receptor. Biochemistry. 1999;38:1751-1756.
25. Smookler DS, Mohammed FF, Kassiri Z, Duncan GS, Mak TW, Khokha R. Tissue inhibitor of metalloproteinase 3 regulates TNF-dependent systemic inflammation. J Immunol. 2006;176:721-725. (Pubitemid 43099666)
26. Hughes DA, Fraser IP, Gordon S. Murine macrophage scavenger receptor: in vivo expression and function as receptor for macrophage adhesion in lymphoid and non-lymphoid organs. Eur J Immunol. 1995;25:466-473.
27. Kunjathoor VV, Febbraio M, Podrez EA, Moore KJ, Andersson L, Koehn S, Rhee JS, Silverstein R, Hoff HF, Freeman MW. Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages. J Biol Chem. 2002;277:49982-49988. (Pubitemid 36014449)
28. Smith GP, Petrenko VA. Phage display. Chem Rev. 1997;97:391-410. (Pubitemid 127659250)
29. Pearson AM, Rich A, Krieger M. Polynucleotide binding to macrophage scavenger receptors depends on the formation of base-quartet-stabilized four-stranded helices. J Biol Chem. 1993;268:3546-3554. (Pubitemid 23070996)
30. Molenaar TJ, Appeldoorn CC, de Haas SA, Michon IN, Bonnefoy A, Hoylaerts MF, Pannekoek H, van Berkel TJ, Kuiper J, Biessen EA. Specific inhibition of p-selectin-mediated cell adhesion by phage displayderived peptide antagonists. Blood. 2002;100:3570-3577. (Pubitemid 35303925)
31. Rensen PC, Gras JC, Lindfors EK, van Dijk KW, Jukema JW, van Berkel TJ, Biessen EA. Selective targeting of liposomes to macrophages using a ligand with high affinity for the macrophage scavenger receptor class a. Curr Drug Discov Technol. 2006;3:135-144. (Pubitemid 44285199)
32. Ngeh J, Anand V, Gupta S. Chlamydia pneumoniae and atherosclerosis: what we know and what we don't. Clin Microbiol Infect. 2002;8:2-13. (Pubitemid 34993754)
33. Sadeghi MM, Glover DK, Lanza GM, Fayad ZA, Johnson LL. Imaging atherosclerosis and vulnerable plaque. J Nucl Med. 2010;51(suppl 1) 51S-65S.
34. Johnson JL, Newby AC. Macrophage heterogeneity in atherosclerotic plaques. Curr Opin Lipidol. 2009;20:370-378.
35. Choudhury RP, Fisher EA. Molecular imaging in atherosclerosis, thrombosis, and vascular inflammation. Arterioscler Thromb Vasc Biol. 2009;29:983-991.
36. de Vries HE, Moor AC, Dubbelman TM, van Berkel TJ, Kuiper J. Oxidized low-density lipoprotein as a delivery system for photosensitizers: implications for photodynamic therapy of atherosclerosis. J Pharmacol Exp Ther. 1999;289:528-534. (Pubitemid 29156071)
37. Beilvert A, Cormode DP, Chaubet F, Briley-Saebo KC, Mani V, Mulder WJ, Vucic E, Toussaint JF, Letourneur D, Fayad ZA. Tyrosine polyethylene glycol (peg)-micelle magnetic resonance contrast agent for the detection of lipid rich areas in atherosclerotic plaque. Magn Reson Med. 2009;62:1195-1201.
38. Cormode DP, Briley-Saebo KC, Mulder WJ, Aguinaldo JG, Barazza A, Ma Y, Fisher EA, Fayad ZA. An apoA-I mimetic peptide high-densitylipoprotein-based MRI contrast agent for atherosclerotic plaque composition detection. Small. 2008;4:1437-1444.
39. Manning-Tobin JJ, Moore KJ, Seimon TA, Bell SA, Sharuk M, Alvarez-Leite JI, de Winther MP, Tabas I, Freeman MW. Loss of SR-A and CD36 activity reduces atherosclerotic lesion complexity without abrogating foam cell formation in hyperlipidemic mice. Arterioscler Thromb Vasc Biol. 2009;29:19-26.